polycystic ovary syndrome, vitamin D, antimullerian hormone, hyperandrogenemia, folliculogenesis, cholecalciferol


Objective. To investigate the relationship between vitamin D and markers of reproductive function in women with polycystic ovary syndrome (PCOS) and to assess of their changes with cholecalciferol.
Materials and methods. Thirty patients with PCOS and 20 healthy women with vitamin D deficiency, who similar for the age and body weight, were examined. Vitamin D, antimullerian hormone (AMH), number of antral follicles, follicle-stimulating hormone (FSH), luteinizing hormone (LH), testosterone (T), estradiol (E2), sex hormone-binding globulin (SHBG), ovarian ultrasound parameters before and after 12 weeks of cholecalciferol therapy at a dose of 4000 IU daily were determined.
Results. Before treatment, was not found association between vitamin D and AMG and the number of antral follicles in both groups. In patients with PCOS was found a negative relationship between vitamin D and T (r = – 0.579; P < 0.001), free androgen index (r = – 503; Р < 0.01), LH/FSH (r = – 0.591, P < 0.001), T/E2 (r = – 0.603; P < 0.001) and positive correlation with SHBG (r = 0.611; P < 0.001), which indicates the role of vitamin D deficiency in the formation of hyperandrogenemia. The therapy of cholecalciferol did not affect the level of AMН, at the same time, was accompanied by changes in gonadotropin secretion and their ratio, reduction of hyperandrogenemia and positive dynamics of folliculogenesis.
Conclusion. We believe that the appointment of vitamin D in patients with PCOS is promising, as it has a positive effect on indicators that reflect the state of reproductive function.


Palomba S, Santagni S, Falbo A, et al. Int J Womens Health 2015; 31(7): 745-63.

Kokanalі D, Karaca M, Ozakşit G, et al. Geburtshilfe Frauenheilkd 2 019; 7 9(5): 5 10-516. h ttps://

De Leo V, Musacchio MC, Cappelli V, et al. Reprod Biol Endocrinol 2016; 14(1): 38.

Ramezanali F, Khalili G, Arabipoor A et al. Int J Fertil Steril 2016;10(1): 36-41.

Kamіns'kij VV, Tatarchuk TF, Dubossars'ka JuV. Reprod Endokrinol 2016;4: 3-14.

Mesinovic J, Teede HJ, Shorakae S, et al. Nutrients 2020;12(5): 1219.

Tatarchuk T, et al. Reprod Endocrinol 2018;3(41): 84-94.

Behmanesh N, Abedelahi A, Charoudeh HN, et al. Turk J Obstet Gynecol 2019;16(3): 143-150. h ttps://

Moolhuijsen LME, Visser JA. J Clin Endocrinol Metab 2020;105(11): 3361-3373.

Ahmed N, Batarfi AA, Bajouh OS, et al. Diagnostics 2019;9(4): 136.

Garg D, Tal R. Reprod Bio Med 2016;33: 15-28.

Bakeer E, Radwan R, El Mandoury A, et al. J Med Biochem 2018;37(4): 448-455.

Krul-Poel YHM, Snackey C, Louwers Y, et al. Eur J Endocrinol 2013;169(6): 853-865. doi:

Moridi I, Chen A, Tal O. Nutrients 2020;12(6): 1567.

Irani M, Minkoff H, Seifer DB, et al. Clin Endocrinol Metab 2014;99(5): E886-890.

Sunmie Kim, Jin Ju Kim, Min-Jeong Kim, et al. Gynecol Endocrinol 2 018;34(4): 3 27-331.

Alavi N, Ebrahimi M, Akbari-Asbagh F. J Reprod Biomed (Yazd) 2020;18(2): 85-92.

Szafarowska M, Dziech E, Kaleta B, et al. J Assist Reprod Genet 2019;36(6): 1281-1289.

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. J Clin Endocrinol Metabol 2011;96(7): 1911-1930. Irani M, Merhi Z. Fertil Steril 2014;102(2): 460-468.

Chang Chu, Tsuprykov O, Xin Chen, et al. Front Endocrinol (Lausanne) 2021.




How to Cite

Arkhypkina, T., Bondarenko , V., & Lyubimovа L. (2021). CONNECTION OF VITAMIN D WITH MARKERS OF REPRODUCTIVE FUNCTION IN PATIENTS WITH WITH POLYCYSTIC OVARY SYNDROME. Problems of Endocrine Pathology, 78(4), 7-13.




Most read articles by the same author(s)

1 2 > >>